Clinical Trials Directory

Trials / Completed

CompletedNCT05109923

Onnit Labs New Mood Supplementation in Healthy College Students

The Effect of Onnit New Mood Supplementation in Healthy Collegiate Men and Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
University of Idaho · Academic / Other
Sex
All
Age
18 Years – 24 Years
Healthy volunteers
Accepted

Summary

The primary purpose of this study is to assess the effectiveness of ONNIT Lab's New Mood™ dietary supplement in supporting optimal mood balance and reducing daily stress among collegiate-aged men and women. To be considered for this study, the participant must meet the following criteria: (1) current undergraduate student at the University of Idaho between 18-24 years of age, (2) have no known allergies to the ingredients of New Mood™ (Niacin, Vitamin B6, Magnesium, Valerian Extract, Lemon Balm Extract, L-Tryptophan. 5-Hydroxytryptophan, and Inositol) or the placebo (rice bran and maltodextrin), (3) not currently taking any mood/sleep supplementation or medications, (4) not currently seeking therapy or diagnosed with a psychological disorder, (5) not regularly using cigarettes, marijuana, or other illicit drugs, and (6) not pregnant or breastfeeding.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMulti-Ingredient Herbal SupplementWeeks 0-2 all participants consumed a placebo lead-in period and weeks 2-6 were intervention weeks. Throughout the 8 weeks (2 weeks placebo lead-in and 6 weeks intervention) participants were asked to consume 2 capsules (multi-ingredient supplement) upon waking in the morning and 2 capsules (multi-ingredient supplement) before bed.
DIETARY_SUPPLEMENTPlacebo SupplementWeeks 0-8 all participants consumed a placebo. Throughout the 8 weeks participants were asked to consume 2 capsules (placebo) upon waking in the morning and 2 capsules (placebo) before bed.

Timeline

Start date
2018-09-10
Primary completion
2019-05-03
Completion
2019-08-02
First posted
2021-11-05
Last updated
2021-11-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05109923. Inclusion in this directory is not an endorsement.